HMGB1 and Stroke: HMGB1 has since been identified as a pathogenic mediator during sepsis, arthritis, cancer, drug-induced liver injury and stroke, among other diseases, and inhibition of HMGB1 is beneficial in several experimental models (Andersson and Tracey 2011).